Literature DB >> 8724220

The epidemiology and control of open angle glaucoma: a population-based perspective.

J M Tielsch1.   

Abstract

Chronic open angle glaucoma is an etiologically heterogeneous group of diseases characterized by damage to the optic nerve, resulting in peripheral visual loss that can progress to involve the fovea and central vision. Open angle glaucoma can be divided into primary conditions and conditions which are secondary to another ocular or systemic disease. Causes of secondary glaucoma include uveitis, cataract, trauma, and disorders affecting the development structure of the angle. This review focuses on primary open angle glaucoma (POAG), since it accounts for the vast majority of the disease burden in the US population and its etiology remains unknown.

Entities:  

Mesh:

Year:  1996        PMID: 8724220     DOI: 10.1146/annurev.pu.17.050196.001005

Source DB:  PubMed          Journal:  Annu Rev Public Health        ISSN: 0163-7525            Impact factor:   21.981


  18 in total

1.  Clinical characteristics of newly diagnosed primary, pigmentary and pseudoexfoliative open-angle glaucoma in the Collaborative Initial Glaucoma Treatment Study.

Authors:  David C Musch; Takayuki Shimizu; Leslie M Niziol; Brenda W Gillespie; L Frank Cashwell; Paul R Lichter
Journal:  Br J Ophthalmol       Date:  2012-07-06       Impact factor: 4.638

Review 2.  Topical medication instillation techniques for glaucoma.

Authors:  Li Xu; Xuemei Wang; Meijing Wu
Journal:  Cochrane Database Syst Rev       Date:  2017-02-20

3.  Relationship between intraocular pressure, anterior chamber depth and lens thickness in primary open-angle glaucoma patients.

Authors:  Bolajoko A Adewara; Bernice O Adegbehingbe; Oluwatoyin H Onakpoya; Chidi G Ihemedu
Journal:  Int Ophthalmol       Date:  2017-03-13       Impact factor: 2.031

4.  Dallas Glaucoma Registry: Preliminary Results.

Authors:  Karanjit S Kooner; Arun Joseph; Adam Shar; Francisco A Marquardt; Mohannad AlBdoor; Byung J Cho; Jess T Whitson; Nalini Aggarwal; Beverley Adams-Huet
Journal:  J Clin Exp Ophthalmol       Date:  2011-06-03

5.  Mathematical modeling approaches in the study of glaucoma disparities among people of African and European descents.

Authors:  Giovanna Guidoboni; Alon Harris; Julia C Arciero; Brent A Siesky; Annahita Amireskandari; Austin L Gerber; Andrew H Huck; Nathaniel J Kim; Simone Cassani; Lucia Carichino
Journal:  J Coupled Syst Multiscale Dyn       Date:  2013-04-01

6.  Glaucoma in southwest Nigeria: clinical presentation, family history and perceptions.

Authors:  Bola J Adekoya; Shaheen P Shah; Adeola O Onakoya; Abdulkabir A Ayanniyi
Journal:  Int Ophthalmol       Date:  2014-01-19       Impact factor: 2.031

7.  Diurnal tension curves for assessing the development or progression of glaucoma: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2011-06-01

8.  Routine eye examinations for persons 20-64 years of age: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-07-01

9.  Projected impact of travoprost versus both timolol and latanoprost on visual field deficit progression and costs among black glaucoma subjects.

Authors:  Michael T Halpern; David W Covert; Alan L Robin
Journal:  Trans Am Ophthalmol Soc       Date:  2002

10.  The association between thyroid problems and glaucoma.

Authors:  J M Cross; C A Girkin; C Owsley; G McGwin
Journal:  Br J Ophthalmol       Date:  2008-10-16       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.